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Red blood cells (RBCs), which constitute the most abundant cell type in the body, come
in two distinct flavors- primitive and definitive. Definitive RBCs in mammals circulate
as smaller, anucleate cells during fetal and postnatal life, while primitive RBCs circulate
transiently in the early embryo as large, nucleated cells before ultimately enucleating.
Both cell types are formed from lineage-committed progenitors that generate a series
of morphologically identifiable precursors that enucleate to form mature RBCs. While
definitive erythroid precursors mature extravascularly in the fetal liver and postnatal
marrow in association with macrophage cells, primitive erythroid precursors mature as
a semi-synchronous cohort in the embryonic bloodstream. While the cytoskeletal network
is critical for the maintenance of cell shape and the deformability of definitive RBCs, little is
known about the components and function of the cytoskeleton in primitive erythroblasts.
Erythropoietin (EPO) is a critical regulator of late-stage definitive, but not primitive,
erythroid progenitor survival. However, recent studies indicate that EPO regulates multiple
aspects of terminal maturation of primitive murine and human erythroid precursors,
including cell survival, proliferation, and the rate of terminal maturation. Primitive and
definitive erythropoiesis share central transcriptional regulators, including Gata1 and Klf1,
but are also characterized by the differential expression and function of other regulators,
including myb, Sox6, and Bcl11A. Flow cytometry-based methodologies, developed to
purify murine and human stage-specific erythroid precursors, have enabled comparative
global gene expression studies and are providing new insights into the biology of erythroid
maturation.
Keywords: primitive erythropoiesis, definitive erythropoiesis, yolk sac, globin, cytoskeleton
INTRODUCTION
RBCs comprise the most abundant cell type in the body and
function primarily to transport oxygen and carbon dioxide. More
than a century ago it was recognized that the mature RBCs in
the bloodstream of mammals lack a nucleus, while the RBCs
of adult birds, amphibians, and fish retain a nucleus through-
out their lifespan in the circulation (Gulliver, 1875). Examination
of the bloodstream of developing mammalian embryos at the
beginning of the last century revealed the presence of two dis-
tinct, temporally overlapping populations of erythroid cells. The
earliest population consisted of larger, nucleated cells and the
subsequent population consisted of smaller, enucleated RBCs
(Maximow, 1909). The transient presence of the larger, nucleated
erythroid cells during early development was termed “primi-
tive” erythropoiesis to distinguish it from the “definitive” form
of erythropoiesis that occurred not only during late fetal life
but throughout all of postnatal life. This review provides an
overview of primitive and definitive erythropoiesis and relies pri-
marily on studies of the mouse as a model of mammalian biology
where these distinct erythroid lineages have been most intensively
studied.
DEFINITIVE ERYTHROPOIESIS
Definitive erythropoiesis occurs in the fetal liver and postnatal
bone marrow and is characterized by the movement of lineage-
committed cells through progenitor, precursor, and mature
RBC compartments (Figure 1). The progenitor and precursor
compartments occur in protected extravascular spaces and are
associated with cellular amplification and maturation. These
compartments sustain the third, functional compartment, which
consists of RBCs circulating within the vascular network.
DEFINITIVE ERYTHROID PROGENITORS
The most immature erythroid compartment consists of
lineage-committed, definitive erythroid progenitors, termed
burst-forming unit erythroid (BFU-E) and colony-forming unit
erythroid (CFU-E). These progenitors are defined by their ability
to form colonies of mature erythroid cells in semisolid media.
BFU-E-derived colonies require 7 and 14 days in mouse and
human systems, respectively, to form mature colonies typically
containing more than a thousand erythroid cells. In contrast, the
more mature CFU-E progenitors require only 2 and 7 days in
mouse and human systems, respectively, to form mature colonies
that consist of only 16–32 cells. Thus, CFU-E are only 4–5 cell
divisions upstream of mature RBCs.
The cytokine erythropoietin (EPO) is necessary for the abil-
ity of CFU-E to generate colonies in vitro. CFU-E are exquisitely
dependent on EPO for their survival (Koury and Bondurant,
1990). EPO levels in the bloodstream, regulated by hypoxia,
are thought to modulate the number of CFU-E in the mar-
row and thus regulate the output of definitive RBCs (Koury
and Bondurant, 1992). EPO acts through its specific receptor,
EPOR, characterized by a single transmembrane domain that
dimerizes upon ligand activation. Downstream signals occur
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FIGURE 1 | Overview of primitive and definitive erythropoiesis. Both
forms of erythroid cell production are characterized by the progressive
movement of cells through three compartments: progenitors, erythroblast
precursors, and red blood cells (RBCs). Erythroid progenitors (BFU-E,
CFU-E, and EryP-CFC) are defined by their capacity to form colonies of
maturing erythroid cells in vitro. Erythroid precursors are defined
morphologically as proerythroblasts (ProE), basophilic erythroblasts (Baso),
polychromatophilic erythroblasts (PolyE), and orthochromatic erythroblasts
(OrthoE). OrthoE enucleate to form a pyrenocyte, that contains the
condensed nucleus, and a reticulocyte (Retic), that goes on to mature into a
RBC. Definitive erythropoiesis in the adult organism is derived from
hematopoietic stem cells (HSC), while primitive erythropoiesis occurs just
once from mesoderm cells in the early embryo.
through Jak2/Stat5, PI3K/AKT, and MAPK pathways (reviewed
by Richmond et al., 2005). The importance of EPO signaling
through its cognate receptor was demonstrated by the identi-
cal phenotype of EPO-null and EPOR-null mice: fetal death at
embryonic day 13.5 (E13.5) associated with severe anemia and
the complete lack of definitive RBCs (Wu et al., 1995; Kieran
et al., 1996; Lin et al., 1996). The restoration of EPOR specifically
in erythroid lineages rescued the lethal phenotype, indicating
that anemia is indeed the cause of in utero death (Suzuki et al.,
2002). Recent studies provide evidence that BFU-E and CFU-
E can undergo limited self-renewal, particularly in response to
acute stress such as anemia and that the self-renewal of CFU-E
is dependent on the action of EPO (Flygare et al., 2011; Peslak
et al., 2012).
DEFINITIVE ERYTHROID PRECURSORS
The second erythroid compartment consists of morphologically
identifiable, nucleated precursors that progress from proery-
throblast (ProE) to basophilic (BasoE), polychromatophilic
(PolyE), and orthochromatic (OrthoE) forms (Figure 1).
Erythroid precursor maturation is characterized by progressive
(1) erythroblast expansion through a limited set of symmetric
cell divisions, (2) accumulation of hemoglobin, (3) decrease in
cell size, (4) nuclear pyknosis, and (5) decrease in RNA content.
The morphologic criteria distinguishing these cells has relied
primarily on the progressive nuclear condensation combined
with changes in cytoplasmic staining, which reflects the degree
of hemoglobin and RNA content (Figure 1). Enhanced flow
cytometric approaches to distinguish these subpopulations have
been developed for both mouse and human systems and have
provided the capacity to analyze large numbers of cells and to
physically isolate these precursors for further study (Koulnis
et al., 2011; Hu et al., 2013; Kingsley et al., 2013; Liu et al.,
2013). In addition, an imaging flow cytometry-based approach,
which weds immunophenotypic analyses with characterization
of morphologic features, has been developed to quantify multiple
cellular aspects associated with progressive erythroid maturation,
including their enucleation (McGrath et al., 2008a; Peslak et al.,
2011, 2012; Konstantinidis et al., 2012).
Definitive erythroblasts mature in the fetal liver and post-
natal bone marrow within erythroblastic islands, composed of
erythroblasts physically attached to central macrophage cells
(reviewed by Chasis and Mohandas, 2008). Macrophages have
been shown to promote erythroblast proliferation, particularly in
the context of stress erythropoiesis (Hanspal et al., 1998; Rhodes
et al., 2008; Chow et al., 2013; Ramos et al., 2013). In mam-
mals, the end result of precursor maturation is enucleation, which
results in the formation of two cell types. The first population
consists of reticulocytes that contain most of the cytoplasm and
hemoglobin, as well as the proteins needed to form a unique
cytoskeletal network (Gaiduschek and Singer, 1979; Koury et al.,
1989; Lee et al., 2004; Liu et al., 2011). The second population
consists of pyrenocytes (“extruded nuclei”) that contain the con-
densed nucleus surrounded by a lipid bilayer and thin rim of
cytoplasm (McGrath et al., 2008a). Enucleation is a complex pro-
cess that involves multiple steps including the establishment of
cell polarity through microtubule action, the formation of a con-
tractile actomyosin ring, vesicle formation, and coalescence of
lipid rafts between reticulocyte and pyrenocytes (Keerthivasan
et al., 2010; Konstantinidis et al., 2012; Wang et al., 2012). Soon
after their formation in the fetal liver and bone marrow, pyreno-
cytes flip phosphotidylserine onto their cell surface, providing an
“eat me” signal, and are rapidly ingested bymacrophages (Yoshida
et al., 2005).
Reticulocyte maturation is a complex process that results in
an approximately 20% loss of plasma membrane surface area,
reduced cell volume, increased association of the cytoskeleton
to the outer plasma membrane, and the loss of all residual
cytoplasmic organelles, including mitochondria and ribosomes
(Johnstone, 1992; Waugh et al., 2001). Organelle clearance occurs
through both autophagy and exocytosis (Griffiths et al., 2012).
The membrane changes convert a multilobulated immature retic-
ulocyte into a biconcave disc with improved viscoelasticity. All of
these changes prepare the reticulocyte for its rigorous sojourn of
45 and 120 days in the bloodstream of adult mice and humans,
respectively.
DEFINITIVE RBCs
The third erythroid compartment consists of circulating reticulo-
cytes and mature RBCs (Figure 1). Steady-state levels of RBCs are
maintained by the continuous production and release of reticu-
locytes into the bloodstream to balance the removal of senescent
RBCs by macrophage cells, which are localized primarily in the
spleen (Bennett and Kay, 1981). In adult humans, this steady-state
production results in the egress of more than 2 million reticulo-
cytes every second into the bloodstream. This incredible number
is estimated as follows: adult humans normally contain approx-
imately 5× 106 RBCs per microliter of blood and the blood
volume of a 70 kg person is approximately 5 l, which amounts
to 2.5× 1013 total circulating RBCs. Since the lifespan of human
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RBCs is approximately 115 days (Franco, 2012), we replace on
average 1/115th of our red cells every day, or 2.2× 1011 RBC/day,
which amounts to 2.5× 106 RBCs/s.
The membrane of mature definitive RBCs is composed of a
cholesterol/phospholipid plasmamembrane to which is anchored
an elastic network of spectrin-based cytoskeletal proteins con-
taining actin and protein 4.1 at their junctions (reviewed by
Mohandas and Gallagher, 2008). The anchoring of the cytoskele-
ton to the lipid bilayer occurs at these junctions through
glycophorin C. In addition, interactions through ankyrin-band
3 stabilize the cytoskeleton to the lipid bilayer. This unique
cytoskeletal network ensures that mature RBCs can passively
deform during their repeated passage through capillary net-
works, yet ultimately maintain their biconcave shape. All of the
components of the cytoskeleton accumulate during erythroblast
maturation (Chen et al., 2009). Abnormalities of cytoskeletal pro-
teins lead to hemolytic disorders in children and adults, including
hereditary spherocytosis and elliptocytosis (Gallagher, 2013).
As RBCs age, surface area and volume, but not hemoglobin,
are progressively lost resulting in increased RBC density.
Senescent RBCs are cleared by splenic macrophages that rec-
ognize, among other changes, clustered band 3 on the RBC
surface (Low et al., 1985). In addition, CD47 interactions with
thrombospondin-1 on senescent RBCs can convert “don’t eat me”
to “eat me” signals leading to RBC clearance by macrophage cells
(Burger et al., 2012).
PRIMITIVE ERYTHROPOIESIS
PRIMITIVE ERYTHROPOIESIS- EMERGENCE IN THE YOLK SAC FROM A
TRANSIENT WAVE OF PROGENITORS
The first blood cells in the mammalian conceptus emerge in
“blood islands” within the yolk sac. These pools of primitive ery-
throblasts differentiate from mesoderm cells soon after the onset
of gastrulation. Examination of carefully staged mouse embryos
revealed the presence of a unique erythroid progenitor, termed
EryP-CFC (Wong et al., 1986; Palis et al., 1999). This transient
wave of EryP-CFC emerges in the yolk sac at E7.25, peaks in
numbers at E8.25, and are no longer detectable at E9.0 (Palis
et al., 1999). EryP-CFC, like their definitive erythroid progeni-
tor counterparts, require the addition of EPO for in vitro colony
formation. Murine EryP-CFC require 5 days of in vitro culture
to form colonies containing several hundred mature primitive
erythroid cells. Thus, EryP-CFC contain a proliferative potential
that is intermediate to that of the definitive BFU-E and CFU-E
progenitors. In addition, primitive erythroid progenitors, unlike
definitive erythroid progenitors, are incapable of even limited
self-renewal when cultured ex vivo in the presence of EPO, SCF
and dexamethasone, a difference associated with the differential
expression of the receptors for the latter two factors (England
et al., 2011).
A global gene expression study of E7.5 and E8.5 primitive ery-
throid cells reveals a gene profile characteristic of high aerobic
glycolysis, suggesting that these progenitors share the “Warburg
effect” with many cancer cell types that are found in hypoxic envi-
ronments (Isern et al., 2011). Consistent with a role for hypoxia
signaling in EryP-CFC, increases in progenitor numbers and in
colony size were detected when yolk sac cells were cultured in low
oxygen compared with room air. Interestingly, low oxygen condi-
tions facilitated the detection of BFU-E in early mouse embryos,
suggesting that hypoxia signaling also plays a role in the emer-
gence of definitive erythroid progenitors in the yolk sac (Borges
et al., 2012).
PRIMITIVE ERYTHROPOIESIS- TERMINAL PRECURSOR MATURATION
Examination of circulating blood cells over developmental
time in rodent embryos revealed that primitive erythroblasts
undergo progressive morphological maturation (Morioka and
Minamikawa-Tachino, 1993; Kingsley et al., 2004; Fraser et al.,
2007). Consistent with their origin from a transient wave of yolk
sac-derived EryP-CFC at E7.5–E8.5, a semi-synchronous wave
of maturing nucleated primitive erythroid precursors is evident
in the mouse embryo between E9.5–E12.5 (Figure 1). Primitive
erythroid precursors mature with progressive characteristics sim-
ilar to their definitive counterparts, including (1) expansion of
erythroblast numbers through a limited set of symmetric cell
divisions, (2) accumulation of hemoglobin, (3) decrease in cell
size, (4) nuclear pyknosis, and (5) decrease in RNA content.
In addition, primitive erythroblasts lose the intermediate fila-
ment vimentin and nuclear histone proteins, changes that also
occur during definitive erythroblast maturation (Sangiorgi et al.,
1990; Morioka et al., 1998). By E12.5, the primitive erythrob-
lasts have matured to an orthochromatic stage and cell division
ceases.
The unique expression in primitive erythroid cells of embry-
onic globin genes both from the beta and from the alpha globin
clusters has facilitated their identification and study, even after
definitive cells have begun to emerge in the fetus. From the
beta globin cluster, the embryonic εy- and βH1-globin genes
are expressed in the mouse, and the ε- and γ-globin genes
are expressed in human (Table 1). In contrast, the “adult” β1-
and β2-globin genes are expressed in the mouse, and “fetal”
γ- and “adult” β-globin genes are expressed in human defini-
tive erythroid cells. From the alpha globin cluster in both
mouse and human, primitive cells also express the embry-
onic ζ- and α-globin genes. The change in the expression of
embryonic, fetal (for human), and adult globin genes during
development has been termed “switching” and has been exten-
sively studied over the past several decades with the ultimate
goal of treating children and adults with hemoglobinopathies
(reviewed by Stamatoyannopoulos, 2005; Sankaran et al., 2010).
Table 1 | Expression of globin genes and transcriptional regulators in
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The transcriptional regulators Sox6 and Bcl11A have been iden-
tified as important regulators of globin gene expression, since
they are expressed in definitive, but not primitive, erythroid cells,
where they act to suppress the expression of embryonic globin
genes (Yi et al., 2006; Sankaran et al., 2009). Erythroid cells can
also switch their hemoglobin expression as they mature. This
has been best characterized in primary mouse primitive ery-
throblasts, which undergo βH1- to εy-globin and ζ- to α-globin
“maturational” globin switches (Kingsley et al., 2006).
For more than a century it was thought that primitive ery-
throblasts remain nucleated throughout their lifespan in the fetal
circulation. However, large, enucleated “megalocytes” having the
same hemoglobin content as nucleated yolk sac erythroblasts
were detected at late stages of gestation in the mouse embryo
(Bethlenfalvay and Block, 1970; Steiner and Vogel, 1973). Using
antibodies specific for embryonic globins to unequivocally iden-
tify primitive erythroid cells, it was determined that primitive
erythroblasts in the mouse fetus enucleate between E12.5–E16.5
of gestation (Kingsley et al., 2004). These findings have been con-
firmed in mice containing a GFP transgene driven by the human
ε-globin promoter to identify primitive erythroid cells (Fraser
et al., 2007). A transient population of primitive pyrenocytes
was also detected during this time period in the fetal circu-
lation of mice (McGrath et al., 2008b). Importantly, the total
number of primitive erythroid cells does not decrease between
E12.5 and E16.5, consistent with the cessation of cell division in
late-stage primitive erythroblasts and the enucleation of the entire
population of primitive erythroid cells (Kingsley et al., 2004).
PRIMITIVE RBCs
Reticulocyte maturation is associated with a significant loss of
surface area and volume associated with remodeling of the
cytoskeleton. Extremely little is known about the components of
membrane cytoskeleton of primitive erythroid cells. The expres-
sion of band 3 and glycophorin A are highly upregulated as early
as E8.5 (Isern et al., 2011). Spectrin and ankyrin transcripts have
been identified in E10.5–E12.5 primitive erythroblasts (Peters
et al., 1992). Since primitive erythroblasts mature in the cir-
culation, they may assemble a functional cytoskeleton prior to
their enucleation and terminal maturation into RBCs. However,
it is not known when during their maturation the cytoskele-
ton is assembled. We have recently examined the biomechanical
properties of murine primitive erythroid cells during the devel-
opmental time they undergo enucleation, i.e., between E12.5 and
E17.5 (Waugh et al., 2013). Late-stage primitive erythroblasts
have membrane deformability similar to mature definitive RBCs,
a finding consistent with their need to survive the stresses of
fetal circulation. As primitive erythroid cells enucleate between
E12.5 and E17.5, the physical association of their outer membrane
bilayer with the underlying cytoskeleton increases. Primitive ery-
throid cells also lose 35% of their surface area and 50% of their
volume between E14.5 and E17.5. Interestingly, the loss of surface
area and volume occurs whether or not the cells are enucleated
(Waugh et al., 2013). These data suggest that, unlike definitive
erythropoiesis, the maturational processes of membrane remod-
eling and enucleation are uncoupled in terminally maturing
primitive erythroid cells.
While the lifespan of primitive RBCs is not known, primitive
RBCs have been detected for several days after birth (Kingsley
et al., 2004; Fraser et al., 2007). These data indicate that primi-
tive RBCs can circulate for at least 5–7 days after they enucleate. It
is not known where or by what mechanisms senescent primitive
RBCs are recognized and cleared from the vasculature.
THE ROLE OF EPO IN PRIMITIVE ERYTHROPOIESIS
The role of EPO in primitive erythropoiesis has been surrounded
by controversy. Early studies showed that EPO failed to increase
heme synthesis in cultures of whole mouse embryos containing
primitive erythroid cells (Cole and Paul, 1966), but the same
group subsequently reported increased heme synthesis when EPO
was added to cultures of disaggregated embryonic cells (Bateman
and Cole, 1971). EPOR transcript expression has been identified
in yolk sac blood islands between E7.5–E8.5 and in the yolk sac
of E9.6–11.5 mouse embryos (McGann et al., 1997; Makita et al.,
2001), while EPOR protein has been quantified on the cell surface
of maturing primitive erythroblasts in the fetal hamster (Boussios
et al., 1988). Furthermore, EPO increased erythroid cell num-
bers and embryonic globin expression in E7.5 yolk sac explants
(Palis et al., 1995). Targeted disruption of EPOR causes a marked
reduction of primitive erythroblasts by E10.5–E11.5 and a pro-
found anemia by E12.5 (Wu et al., 1995; Kieran et al., 1996; Lin
et al., 1996; Malik et al., 2013). Recently, a more detailed anal-
ysis of primitive erythropoiesis in EPOR-null mouse embryos
has revealed important functions of EPOR signaling in termi-
nal erythropoiesis, including reduction of primitive erythroblast
proliferation associated with increased p27 expression, advanced
cellular maturation, and markedly elevated rates of apoptosis
associated with an imbalance in pro- and anti-apoptotic gene
expression (Malik et al., 2013). Little EPO is expressed in the
early mouse yolk sac (Malik et al., 2013), however, neuroepithelial
cells of E8.5–E11.5 mouse embryos have recently been shown to
express EPO and likely serve to support the early maturation of
primitive erythroid precursors (Suzuki et al., 2013).
HUMAN PRIMITIVE ERYTHROPOIESIS
While primitive erythropoiesis has been most thoroughly inves-
tigated in the mouse model, relatively little is known about
primitive erythropoiesis in humans owing both to ethical con-
cerns and to the physical inaccessibility of the early embryo. Blood
islands filled with primitive erythroblasts first arise at 18–20 days
of gestation (Bloom and Bartelmez, 1940; Luckett, 1978; Kelemen
et al., 1979). Primitive erythroblasts are the only circulating ery-
throid cells in human embryos from 3 to 6 weeks of gestation
and nucleated primitive erythroid cells have been identified in
the fetal circulation of the human embryo throughout the first
trimester (Knoll, 1927). Human primitive erythroblasts can phys-
ically interact with macrophages within the placenta and, like
their murine counterparts, also enucleate in vivo (Van Handel
et al., 2010).
Human primitive erythroblasts express the embryonic ε- and
ζ-globin genes. A maturational ζ- to α-globin switch occurs
between 5 and 7 weeks of gestation in primitive erythroid cells
(Peschle et al., 1985). Primitive erythroid cells derived from the
in vitro differentiation of human ES cells can serve as a surrogate
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model system for early stages of human development. Studies of
embryonic stem cell-derived human primitive erythroblasts indi-
cate that they, like their primary counterparts, undergo a “matu-
rational” switch from hemoglobin Gower I (ζ2ε2) to hemoglobin
Gower II (α2ε2) (Qiu et al., 2008). Recently, primitive erythrob-
lasts derived from human ES have been shown to require EPO for
their terminal maturation. Similar to primitive erythropoiesis in
EPOR-null embryos, human primitive erythroblasts deprived of
EPO undergo increased apoptosis and accelerated maturation at
late maturational stages (Malik et al., 2013). These studies indi-
cate that the role of EPO in terminal maturation of primitive
erythroid precursors is evolutionarily conserved in mammals.
Little is known about the cytoskeletal network of human
primitive erythroid cells. However, a recent membrane pro-
teomics analysis of primary human primitive erythroblasts reveals
the presence of several cytoskeletal proteins, including spectrin,
ankyrin, band 3, protein 4.1, and dematin, suggesting that the
cytoskeleton of primitive and definitive erythroid lineages share
common structural features (Ponnusamy et al., 2012).
ONTOGENY OF PRIMITIVE AND DEFINITIVE
ERYTHROPOIESIS
THE HEMANGIOBLAST ORIGIN OF PRIMITIVE ERYTHROPOIESIS
The emergence of primitive erythroid cells and a vascular net-
work in close temporal and spatial proximity within the yolk
sac suggested that these lineages might arise from common
“hemangioblast” precursors (Sabin, 1920). This concept has been
validated in the murine embryo using clonal assays, since cells
containing both endothelial and hematopoietic potential have
been localized to the primitive streak of gastrulating mouse
embryos (Huber et al., 2004). Consistent with the emergence
from hemangioblasts precursors, primitive erythroid potential
has been derived from mesodermal cells expressing the endothe-
lial/hematopoietic markers flk1, CD31 and Tie-2 (Ema et al.,
2006). Studies of mouse and human embryonic stem cells dif-
ferentiated in vitro toward blood cell fates also have provided
evidence that hemangioblast precursors arise during gastrula-
tion prior to the onset of hematopoietic progenitor activity (Choi
et al., 1998; Zambidis et al., 2005; Kennedy et al., 2007).
DEFINITIVE ERYTHROPOIESIS- TWO DEVELOPMENTAL ORIGINS
Just as colony assays have been used to define the onset of
primitive erythroid potential, a temporal and spatial analy-
sis of definitive erythroid progenitors (BFU-E) in carefully
staged mouse embryos reveals the onset of definitive ery-
throid potential within the yolk sac at E8.25, just prior to
the onset of circulation (Palis et al., 1999). The emergence
of BFU-E in the yolk sac is associated spatially and tem-
porally with the emergence of multipotential hematopoietic
progenitor cells (Palis et al., 2001), that have been termed
“erythro-myeloid progenitors” (EMP). Definitive erythroid and
multipotential hematopoietic progenitor activity has been gen-
erated in vitro from the culture of hemangioblasts, suggesting
that EMP potential arises from hemangioblast precursors (Lacaud
et al., 2002). Other evidence suggests that definitive hematopoi-
etic potential emerges in the yolk sac from hemogenic endothe-
lial cells composing part of the newly established vasculature
(Li et al., 2005). More research is needed to clarify the devel-
opmental origins of definitive hematopoiesis in the mammalian
embryo.
Following their initial emergence, BFU-E numbers expand
rapidly in the yolk sac, are subsequently found in the blood-
stream, and then in the early fetal liver (Palis et al., 1999). These
yolk sac-derived definitive erythroid progenitors, when cultured
in vitro, express predominantly adult β1- and β2-globins, but
unlike their adult counterparts, they also express small amounts
of the embryonic βH1-globin gene (McGrath et al., 2011). The
first definitive RBCs are detected in the fetal bloodstream between
E11.5 and E12.5 (McGrath et al., 2011). Mouse embryos lacking
a heart beat and a functional circulation, contain similar num-
bers of BFU-E in the yolk sac but fail to distribute those BFU-E to
the embryo proper, supporting the concept that the first definitive
erythroid potential found in the fetal liver originates in the yolk
sac (Lux et al., 2008). Interestingly, BFU-E in the human embryo
are first detected in the yolk sac as early as 4–5 weeks gestation
(Migliaccio et al., 1986). Similar to findings in the mouse, BFU-E
are subsequently found in the fetal liver of the human embryo as
soon as it begins to form as an organ (Migliaccio et al., 1986).
These data indicate that definitive erythropoiesis first emerges
after the onset of gastrulation in the yolk sac and seeds the early
fetal liver.
In the adult, all blood cell lineages are derived from
hematopoietic stem cells that are assayed by their ability to repop-
ulate the entire blood system of lethally irradiated adult hosts.
Using this functional assay, the first hematopoietic stem cells in
the mouse embryo have been found to emerge, not from the yolk
sac at E8.25, but from major arterial vessels, including the aorta,
beginning at E10.5 (Kumaravelu et al., 2002). Hematopoietic stem
cell activity subsequently expands in the fetal liver, peaking there
at E16.5, and subsequently transitions to its long-term resident
location in the bone marrow (Ema and Nakauchi, 2000; Wolber
et al., 2002). This transition begins by E17.5 and 10–11 weeks in
mouse and human embryos, respectively, but is not completed
until after birth (Kelemen et al., 1979; Charbord et al., 1996;
Blazsek et al., 2000).
Taken together, these studies support the conclusion that
definitive erythropoiesis has two developmental origins. The first
originates in the yolk sac of mouse and human embryos as a tran-
sient lineage that generates the first circulating definitive RBCs
that emerge from the fetal liver. This transient definitive erythroid
system is ultimately replaced by a second, permanent blood sys-
tem, derived from hematopoietic stem cells, that provides for
lifelong RBC production. However, further research is required
to establish the timing of this transition from yolk sac-derived to
hematopoietic stem cell-derived definitive erythropoiesis.
TRANSCRIPTIONAL REGULATION OF PRIMITIVE AND
DEFINITIVE ERYTHROPOIESIS
Transcription factors play critical roles driving lineage-specific
cellular maturation. The Gata1 transcription factor plays a central
role in the regulation of erythroid-specific genes both in prim-
itive and in definitive erythroid cells. Disruption of Gata1 leads
to the maturational arrest of both primitive and definitive ery-
throid lineages at the proerythroblast stage (Pevny et al., 1995;
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Fujiwara et al., 1996). Different functional domains of GATA1
are required to activate target genes in primitive vs. definitive
erythroid cells (Shimizu et al., 2001), suggesting that differ-
ent Gata1-containing transcriptional complexes may function in
these lineages. Transcriptional regulators that can complex with
Gata1 include Ldb1, FOG1, Scl/Tal1, and Lmo2. Targeted disrup-
tion of each of these genes leads to marked defects in primitive
and definitive erythroid cells (Warren et al., 1994; Robb et al.,
1995; Shivdasani et al., 1995; Tsang et al., 1998; Li et al., 2010).
Another important transcriptional regulator of erythropoiesis
is the erythroid-specific Kruppel-like factor Klf1/EKLF (Miller
and Bieker, 1993). Klf1 regulates the expression of several
erythroid-specific genes including the adult and embryonic
globins, alpha-hemoglobin stabilizing protein, heme biosynthetic
enzymes, several transcription factors, as well as cytoskeletal
proteins and blood group antigens that are expressed both in
primitive and in definitive erythroid cells (Hodge et al., 2006;
Nilson et al., 2006; Basu et al., 2007). Loss of even one allele of Klf1
significantly decreases the expression of Ter119 on the surface of
primitive erythroblasts (Isern et al., 2010). Consistent with Klf1
regulation of multiple cytoskeletal genes, Klf1-null primitive ery-
throblasts display markedly abnormal cell membranes and ruffled
cell surfaces.
While the primitive and definitive erythroid lineages share
many transcription factors central to erythropoiesis, there are also
several transcriptional regulators that are differentially expressed
and function differentially in embryonic vs. fetal/adult erythroid
lineages. Targeted disruption of the Myb gene completely blocks
the maturation of definitive erythroblasts in the fetal liver but
has no discernable effect in primitive erythropoiesis (Mucenski
et al., 1991; Tober et al., 2008). Interestingly, Myb-null mouse
embryos die of progressive anemia, but only after E15.5, indicat-
ing that the primitive erythroid lineage can support survival of
the mouse fetus throughout most of its gestation. Humans with
Trisomy 13 have persistence of embryonic and fetal hemoglobins
associated with dysregulation of the Myb gene and upstream
microRNas in fetal erythroblasts (Sankaran et al., 2011). Sox6
and Bcl11A are additional differentially expressed transcriptional
regulators that down-regulate embryonic and fetal globin gene
expression (Yi et al., 2006; Xu et al., 2010). Other transcription
factors differentially expressed between primitive and defini-
tive erythroid lineages have been identified through comparative
bioinformatic analyses (Kingsley et al., 2013), however, func-
tional studies confirming their differential expression and poten-
tial functions in the regulation of erythropoiesis have not been
reported.
The complex interaction of transcription factors in the regu-
lation of erythroid development has been modeled (Swiers et al.,
2006). A summary of some of the key transcription factors reg-
ulating primitive and definitive erythropoiesis is provided in
Table 1. In addition to the action of master erythroid transcrip-
tion factors, it has recently been recognized that interferon reg-
ulatory factors, including IRF2 and IRF8, cooperate with Gata1
and Tal1, to regulate adult, but not fetal, human erythropoiesis
(Xu et al., 2012). Interestingly, Irf8 is not expressed in primi-
tive erythroblasts and IFNγ inhibits adult mouse definitive, but
not primitive, erythroid colony formation (Greenfest-Allen et al.,
2013). These data, taken together, suggest that inflammatory
signals regulate adult, but not embryonic or fetal, erythropoiesis.
Several global gene expression analyses derived from primary
primitive or definitive erythroid cells at various stages of mat-
uration are available (Miller, 2004; Redmond et al., 2006; Isern
et al., 2011; Merryweather-Clarke et al., 2011). Of note, a com-
parative analysis of global gene expression in similarly staged
primitive, fetal definitive, and adult definitive erythroid cells has
recently been published (Kingsley et al., 2013). A user-friendly
website (http://www.cbil.upenn.edu/ErythronDB) has also been
established, making these data readily available to the scientific
community to facilitate comparative expression studies. The dif-
ferential expression of globin genes, as well as several of their tran-
scriptional regulators, have served as the primary genetic feature
distinguishing primitive and definitive erythropoiesis (Table 1).
In addition, several aquaporin gene family members were recently
identified to be differentially expressed in primitive vs. adult
definitive mouse erythroblasts (Kingsley et al., 2013). The expres-
sion of aquaporins 1 and 9 were confirmed in adult RBCs, while
the specific expression of aquaporins 3 and 8 in primitive, but
not adult definitive, erythroid cells correlates with their ability
to accumulate reactive oxygen species when exposed to exoge-
nous hydrogen peroxide. These studies raise the possibility that
primitive erythroid cells may serve as a sink to protect the early
embryo from free radical injury. Comparative global gene expres-
sion studies should continue to provide new insights into the
biology of primitive and definitive erythroid maturation.
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